醒脑静注射液治疗缺血性脑梗死临床观察.docVIP

醒脑静注射液治疗缺血性脑梗死临床观察 　　[摘要] 目的 分析醒脑静注射液治疗缺血性脑梗死的临床体会。 方法 选取我院在2015年5月～2017年5月收治的60例缺血性脑梗死患者，将其分为对照组和观察组，对照组给予丹参酮治疗，观察组给予醒脑静注射液治疗，对比分析两组患者的临床治疗效果。 结果 观察组总有效率为90.00%（27/30），显著高于对照组的66.67%（20/30），差异有统计学意义（P0.05）；经过治疗后，两组神经损伤评分均降低，且观察组的神经损伤评分明显低于对照组，差异有统计学意义（P0.05）；两组患者治疗后的GCS评分明显升高，观察组的GCS评分明显高于对照组，差异有统计学意义（P0.05）。 结论 在缺血性脑梗死患者的常规治疗基础上实施醒脑静注射液治疗，疗效显著、安全性高，可以有效改善患者的脑神经功能，具有较好的应用价值。 　　[关键词] 醒脑静注射液；缺血性脑梗死；脑神经功能；临床观察 　　[中图分类号] R743.3 [文献标识码] B [文章编号] 1673-9701（2017）34-0043-03 　　Clinical observation of Xingnaojing injection in treating ischemic cerebral infarction 　　YU Chun 　　Department of Neurology， the Third Peoples Hospital of Jingdezhen City in Jiangxi Province， Jingdezhen 333000， China 　　[Abstract] Objective To analyze the clinical experience of Xingnaojing injection in treating ischemic cerebral infarction. Methods 60 ischemic cerebral infarction patients in our hospital from May 2015 to May 2017 were selected and divided into control group and observation group. The control group was treated with tanshinone. The observation group was treated with Xingnaojing injection. The clinical treatment effect between the two groups of patients were compared and analyzed. Results The total effective rate in the observation group was 90.00%（27/30）， significantly higher than that in the control group （66.67%， 20/30）， and the difference was statistically significant（P0.05）. After treatment， the nerve injury scores of patients all decreased. The score of neurological injury in the observation group was significantly lower than that in the control group， and the difference was statistically significant（P0.05）. The GCS scores of the two groups was significantly increased after treatment. The GCS score of the observation group was significantly higher than that of the control group ， and the difference was significant （P0.05）. Conclusion Xingnaojing injection treatment on the basis of conventional treatment applied in ischemic cerebral infarction has significant effect and high s